Substance

ID:346903

Names and Identifiers
IUPAC Traditional name
pemoline
Synonyms
Phenylisohydantoin苯异妥因Pemoline2-氨基-5-苯基 4(5H)-噁唑酮匹莫林2-Amino-5-phenyl4(5H)-oxazolone
IUPAC name
2-amino-5-phenyl-4,5-dihydro-1,3-oxazol-4-one
Registration numbers
MDL Number
CAS Number
EC Number
Properties
Safety Information
GHS Hazard statements
H302-H312-H332
Safety Statements
36/37
Risk Statements
20/21/22
German water hazard class
3
European Hazard Symbols
Harmful Harmful (Xn)
Storage Temperature
2-8°C
GHS Precautionary statements
P280
Drug Control
USDEA Schedule IV; Home Office Schedule 4.2; psychotrope; kontrollierte Droge in Deutschland; regulated under CDSA - not available from Sigma-Aldrich Canada
GHS Signal Word
Warning
MSDS Link
GHS Pictograms
GHS07
Acute toxicity (oral, dermal, inhalation), category 4
Skin irritation, category 2
Eye irritation, category 2
Skin sensitisation, category 1
Specific Target Organ Toxicity – Single exposure, category 3
Personal Protective Equipment
Eyeshields, Faceshields, full-face particle respirator type N100 (US), Gloves, respirator cartridge type N100 (US), type P1 (EN143) respirator filter, type P2 (EN 143) respirator cartridges, type P3 (EN 143) respirator cartridges
RTECS
RQ2975000
Physical Property
Apperance
solid
Solubility
DMSO: soluble28 mg/mL
Product Information
Empirical Formula (Hill Notation)
C9H8N2O2
Purity
≥98% (HPLC)
Molecule Details
Biochem/physiol Actions
Pemoline is a CNS stimulant. Pemoline is used to treat attention-deficit hyperactivity disorder (ADHD). Pemoline is a Schedule IV drug and offers some advantages over other stimulants in that it does not reduce the appetite or cause dry mouth.
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data